Case Report of Multisystem Inflammatory Syndrome in Adults (MIS-A): A 31-Year-Old Man with Fever, Rash, and Cardiac Symptoms 6 Weeks Following SARS-CoV-2 Infection, Successfully Resuscitated Following Cardiac Arrest.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
22 Nov 2022
22 Nov 2022
Historique:
entrez:
22
11
2022
pubmed:
23
11
2022
medline:
24
11
2022
Statut:
epublish
Résumé
BACKGROUND Multisystem inflammatory syndrome in adults (MIS-A) is an uncommon condition after a confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, manifesting as multiorgan failure despite apparent resolution of initial symptoms. While this syndrome shares similar characteristics with a syndrome found in children, fewer cases are reported in adults. This report details a 31-year-old man fulfilling the diagnostic criteria of MIS-A, who was successfully resuscitated following cardiac arrest. CASE REPORT A 31-year-old man was admitted to the intensive care unit for 3 days of progressively worsening fever, chills, diaphoresis, exanthematous rash, headache, and neck stiffness. The patient had a history of mild, resolved SARS-CoV-2 infection 6 weeks prior to his presentation, diagnosed by rapid antigen and reverse transcription polymerase chain reaction (RT-PCR) testing. Meningitis and autoimmune pathologies were initially suspected but were ruled out. Given the patient's symptoms, prior SARS-CoV-2 infection, and positive inflammatory markers, findings correlated with the Centers for Disease Control and Prevention's diagnostic criteria for multisystem inflammatory syndrome in adults. On hospital day 1, the patient decompensated into severe respiratory distress requiring intubation. Shortly after, the patient developed cardiac arrest and was successfully resuscitated. He was transferred from our rural hospital to an intensive care unit at a facility with additional resources. He remained critically ill for several weeks while receiving high-dose steroids, intravenous immunoglobulin (IVIG), and hemodialysis until his recovery. CONCLUSIONS Early diagnosis and treatment of MIS-A would significantly improve outcomes in this subset of patients, especially in clinical settings with limited resources.
Identifiants
pubmed: 36411724
pii: 938127
doi: 10.12659/AJCR.938127
pmc: PMC9701531
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e938127Références
Pain Rep. 2021 Apr 13;6(1):e913
pubmed: 33987484
Nat Rev Immunol. 2020 Aug;20(8):453-454
pubmed: 32546853
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
J Thromb Thrombolysis. 2021 Apr;51(3):587-594
pubmed: 33501596
JAMA Netw Open. 2021 Sep 01;4(9):e2126456
pubmed: 34550381
Eur Heart J Case Rep. 2021 Oct 01;5(10):ytab381
pubmed: 34661054
Front Immunol. 2020 Sep 24;11:558898
pubmed: 33072097
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
Int J Hematol. 2021 Jan;113(1):45-57
pubmed: 33161508
Pediatr Infect Dis J. 2020 Nov;39(11):e340-e346
pubmed: 32925547
Front Immunol. 2021 Dec 09;12:779026
pubmed: 34956207
Children (Basel). 2020 Jul 01;7(7):
pubmed: 32630212
J Clin Med. 2021 Dec 16;10(24):
pubmed: 34945213
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Eur Heart J Case Rep. 2021 Nov 19;5(12):ytab470
pubmed: 35047731
BMC Cardiovasc Disord. 2021 Oct 29;21(1):522
pubmed: 34715788
J Med Case Rep. 2021 Dec 13;15(1):590
pubmed: 34903290
N Engl J Med. 2020 Jul 23;383(4):393-395
pubmed: 32598829
JAMA Dermatol. 2020 Jul 1;156(7):819-820
pubmed: 32352486
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e304-e306
pubmed: 32330336
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456
pubmed: 33031361
Vaccine. 2021 May 21;39(22):3037-3049
pubmed: 33640145